Litcius/Paper detail

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Erin M. Parry, Camilla K. Lemvigh, Stephanie Deng, Nathan Dangle, Neil Ruthen, Binyamin A. Knisbacher, Julien Broséus, Sébastien Hergalant, Romain Guièze, Shuqiang Li, Wandi Zhang, Connor Johnson, Jaclyn M. Long, Shanye Yin, Lillian Werner, Annabelle Anandappa, Noelia Purroy, Satyen H. Gohil, Giacomo Oliveira, Pavan Bachireddy, Sachet A. Shukla, Teddy Huang, Joseph D. Khoury, Beenu Thakral, Michael Dickinson, Constantine S. Tam, Kenneth J. Livak, Gad Getz, Donna Neuberg, Pierre Feugier, Peter V. Kharchenko, William G. Wierda, Lars Rønn Olsen, Nitin Jain, Catherine J. Wu

2023Cancer Cell73 citationsDOIOpen Access PDF

Topics & Concepts

ImmunityCD8ImmunologyPopulationMedicineCytotoxic T cellCancer researchBiologyImmune systemGeneticsIn vitroEnvironmental healthCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionT-cell and B-cell Immunology
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome | Litcius